Skip to main content
OpenTrials

Clinical trial condition

Recurrent Malignant Glioma

Explore clinical trials studying Recurrent Malignant Glioma. Study availability and eligibility vary by location and protocol.

24 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Malignant Glioma trial results

Recruiting

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

NCT05278208

Conditions
Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

NCT02658279

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Active, not recruiting

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04320888

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +85 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 174 locations
View Trial Details
Active, not recruiting

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

NCT03598244

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +25 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details

Related conditions